Nova Eye launches more effective glaucoma surgery device

Medical device manufacturer Nova Eye Medical has made the first shipments to surgeons of its new iTrack Advance consumable device (pictured, below) to be used in glaucoma surgery.

The device has an illuminated fibre optic tip, and is designed to improve the efficacy of canaloplasty surgery in treating glaucoma, and can be utilised by ophthalmologists, a large new market, as well as cataract surgeons.

The company has begun the commercial roll out of the next generation device in Europe and the Asia Pacific, with an initial focus on the German market.

According to the company, the first commercial, in-human cases have now been completed.

Nova Eye Medical managing director Tom Spurling said: “With a number of industry-leading features and backed by a strong IP portfolio, we expect iTrack Advance to drive improved sales performance for the group during the 2023 fiscal year.”

Spurling said the company had noted a marked increase in interest in canaloplasty across its markets, and early sales numbers and surgeon feedback were encouraging.

“The introduction of the iTrack Advance underscores our commitment to grow the canaloplasty field.”

Melbourne ophthalmic surgeon Dr Nathan Kerr, an authority on minimally invasive glaucoma surgery, recently performed the world’s first surgical case with the iTrack Advance.

Dr Kerr, head of glaucoma surgical trials at the Centre for Eye Research Australia, said: “The iTrack Advance is a revolutionary device, combining the proven efficacy of the iTrack microcatheter canaloplasty in an ergonomic and easy to use preloaded handheld injector.

“The iTrack Advance can be performed with cataract surgery or as a standalone procedure.

“Without the need for an implant or surgeons, the iTrack Advance is designed to lower eye pressure and may reduce or eliminate the need for glaucoma eye drops.”

Pictures: Nova Eye Medical

Subscribe to our free @AuManufacturing newsletter here.

Share this Story

Stay Informed

Go to Top